secwatch / observer

Executive movement radar

Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.

Launch 76368 grounded facts newest September 3, 2026, 9:03 AM ET RSS · JSON

Showing 6951–7000 of 18650

Departed

Dr. Neil Campbell

President and Chief Executive Officer
ONCO · Onconetix, Inc.
Effective
2024-01-10
Successor
Dr. Ralph Schiess
Filed
January 12, 2024, 6:59 PM ET
Effective as of January 10, 2024, Dr. Neil Campbell resigned as President and Chief Executive Officer and a member of the Board of Directors (the “Board”) of Onconetix, Inc. (the “Company”).
Appointed (interim)

Dr. Ralph Schiess

Interim Chief Executive Officer
ONCO · Onconetix, Inc.
Effective
2024-01-12
Filed
January 12, 2024, 6:59 PM ET
On January 12, 2024, the Board appointed Dr. Ralph Schiess, the Company’s Chief Science Officer, to serve as the Company’s Interim Chief Executive Officer.
Departed

Leonid Gontmakher

Chief Executive Officer
4Front Ventures Corp.
Effective
2024-01-08
Successor
Andrew Thut
Filed
January 12, 2024, 6:59 PM ET
Effective January 8, 2024, Leonid Gontmakher resigned as Chief Executive Officer of 4Front Ventures Corp. (the “Company”).
Role change

Andrew Thut

Chief Executive Officer
4Front Ventures Corp.
Effective
2024-01-08
Filed
January 12, 2024, 6:59 PM ET
Effective January 8, 2024, the Company promoted Andrew Thut to Chief Executive Officer of the Company.
Departed

Jay Wintrob

Chief Executive Officer
OAK-PA · Brookfield Oaktree Holdings, LLC
Effective
2024-03-01
Filed
January 12, 2024, 6:59 PM ET
The effective date of Mr. Wintrob’s cessation of service as chief executive officer of OCG and a member of the board of directors of OCG has been determined to be March 1, 2024.
Departed

Simon Stadil

Chief Financial Officer
LIQT · LIQTECH INTERNATIONAL INC
Effective
2024-04-10
Filed
January 12, 2024, 6:59 PM ET
On January 10, 2024, Simon Stadil tendered his resignation as Chief Financial Officer of LiqTech International, Inc. (the " Company "), effective as of April 10, 2024.
Role change

Doug Cole

President and Chief Executive Officer
MTWO · M2i Global, Inc.
Effective
2023-12-11
Successor
Jeffrey W. Talley
Filed
January 12, 2024, 6:59 PM ET
In connection with Mr. Talley’s appointment to President and Chief Executive Officer, Mr. Doug Cole resigned from the President and Chief Executive Officer roles of the Company, but still maintains his roles as Executive Chairman and Chief Financial Officer.
Appointed

Jeffrey W. Talley

President and Chief Executive Officer
MTWO · M2i Global, Inc.
Effective
2023-12-11
Filed
January 12, 2024, 6:59 PM ET
On December 11, 2023, M2i Global, Inc. (“the Company”) appointed Lieutenant General (Ret) Jeffrey W. Talley, age 64, as President and Chief Executive Officer of the Company.
Departed

Stuart P. Crumbaugh

chief financial officer
MGLD · Marygold Companies, Inc.
Effective
2024-01-12
Filed
January 12, 2024, 6:59 PM ET
Effective January 12, 2024, The Marygold Companies, Inc. (the “Company”) has accepted the resignation of Stuart P. Crumbaugh on the Company’s Board of Directors and as its chief financial officer.
Appointed

Rongguo Wei

Chief Financial Officer
HWH · HWH International Inc.
Effective
2024-01-09
Filed
January 12, 2024, 6:59 PM ET
Rongguo Wei 52 Chief Financial Officer
Appointed

John "JT" Thatch

Chief Executive Officer
HWH · HWH International Inc.
Effective
2024-01-09
Filed
January 12, 2024, 6:59 PM ET
Additionally, on January 9, 2024, John “JT” Thatch has been appointed to the Chief Executive Officer of the Company.
Departed

Patrick L. Bridges

Senior Vice President and Chief Financial Officer
Tri-State Generation & Transmission Association, Inc.
Successor
Todd Telesz
Filed
January 12, 2024, 6:59 PM ET
Patrick L. Bridges, our Senior Vice President and Chief Financial Officer, informed us that he intends to retire in March 2024 after more than 17 years of service to us.
Appointed

Todd Telesz

Senior Vice President and Chief Financial Officer
Tri-State Generation & Transmission Association, Inc.
Effective
2024-01-29
Filed
January 12, 2024, 6:59 PM ET
On January 12, 2024, Todd Telesz, age 52, accepted the position to succeed Mr. Bridges as our Senior Vice President and Chief Financial Officer effective January 29, 2024.
Departed

Eliot M. Lurier

Chief Financial Officer
TENX · TENAX THERAPEUTICS, INC.
Successor
Lawrence R. Hoffman
Filed
January 12, 2024, 6:59 PM ET
Mr. Hoffman succeeds Eliot M. Lurier, who passed away in December 2023
Appointed (interim)

Lawrence R. Hoffman

Interim Chief Financial Officer
TENX · TENAX THERAPEUTICS, INC.
Effective
2024-01-11
Filed
January 12, 2024, 6:59 PM ET
On January 9, 2024, the Company’s Board of Directors (the “Board”) appointed Lawrence R. Hoffman as Interim Chief Financial Officer of the Company effective January 11, 2024
Appointed

Dr. Steve Niu

CFO
VNOV · VitaNova Life Sciences Corp
Effective
2024-01-08
Filed
January 12, 2024, 6:59 PM ET
Effective as of January 8, 2024, the Board appointed Dr. Steve Niu as the CFO of the Company, until the next annual meeting of the Company’s stockholders, and until his successor is elected and qualified or until his prior death, resignation or removal.
Departed

Qiuping Lu

CFO
VNOV · VitaNova Life Sciences Corp
Effective
2024-01-08
Successor
Dr. Steve Niu
Filed
January 12, 2024, 6:59 PM ET
Effective as of January 8, 2024, Qiuping Lu resigned from her position as the CFO of Yijia Group Corp (the “Company”).
Role change

Ajay Kataria

Chief Financial Officer
UTZ · Utz Brands, Inc.
Effective
2024-01-12
Filed
January 12, 2024, 6:59 PM ET
designated Mr. Ajay Kataria as the Company’s principal accounting officer
Appointed

Mark Marino

Chief Financial Officer
RXT · Rackspace Technology, Inc.
Effective
2024-01-12
Filed
January 12, 2024, 6:59 PM ET
Effective January 12, 2024, the Company appointed Mr. Mark Marino as Chief Financial Officer.
Departed

Bobby Molu

Executive Vice President and Chief Financial Officer
RXT · Rackspace Technology, Inc.
Effective
2024-01-12
Successor
Mark Marino
Filed
January 12, 2024, 6:59 PM ET
Mr. Naushaza "Bobby" Molu informed the Company of his intention to resign as Executive Vice President and Chief Financial Officer
Appointed (interim)

Alan Gahm

Interim Chief Financial Officer
Heliogen, Inc.
Effective
2024-01-11
Filed
January 12, 2024, 6:59 PM ET
the Board appointed Alan Gahm as interim Chief Financial Officer of the Company, effective on January 11, 2024.
Departed

Sagar Kurada

Chief Financial Officer and Head of Strategy
Heliogen, Inc.
Effective
2024-01-11
Successor
Alan Gahm
Filed
January 12, 2024, 6:59 PM ET
Mr. Kurada will cease to serve as Chief Financial Officer and Head of Strategy of the Company, effective January 11, 2024
Appointed

David Green

Chief Financial Officer
ICU · SeaStar Medical Holding Corp
Effective
2024-01-10
Filed
January 11, 2024, 6:59 PM ET
On January 10, 2024, the Board of Directors (the “Board”) of SeaStar Medical Holding Corporation (the “Company”) appointed David Green, age 61, as the Company’s Chief Financial Officer, effective as of January 10, 2024.
Role change

Michael J. Ressler

Chief Financial Officer, Treasurer & Secretary
FLXS · FLEXSTEEL INDUSTRIES INC
Effective
2024-01-10
Filed
January 11, 2024, 6:59 PM ET
On January 10, 2024, Flexsteel Industries, Inc. (the “Company”) announced that Michael J. Ressler has been promoted to assume the role of Chief Financial Officer, Treasurer & Secretary effective immediately.
Role change

Jerald K. Dittmer

Chief Executive Officer
FLXS · FLEXSTEEL INDUSTRIES INC
Effective
2024-01-10
Successor
Derek P. Schmidt
Filed
January 11, 2024, 6:59 PM ET
On January 10, 2024, in connection with Derek P. Schmidt being appointed President, Jerald K. Dittmer is relinquishing his position as President and will continue to serve as the Chief Executive Officer.
Appointed

J. Erik Fyrwald

Chief Executive Officer and Director
IFF · INTERNATIONAL FLAVORS & FRAGRANCES INC
Effective
2024-02-06
Filed
January 11, 2024, 6:59 PM ET
J. Erik Fyrwald has been appointed CEO of the Company and has been appointed to serve as a director of the Board.
Departed

Franklin K. Clyburn, Jr.

Chief Executive Officer and Director
IFF · INTERNATIONAL FLAVORS & FRAGRANCES INC
Effective
2024-02-06
Successor
J. Erik Fyrwald
Filed
January 11, 2024, 6:59 PM ET
Mr. Franklin K. Clyburn, Jr. who is currently Chief Executive Officer (“CEO”) of the Company and a director of the Company’s Board of Directors (the “Board”), will cease to serve as CEO and a director of the Board, effective February 6, 2024.
Appointed

Owen Hughes

Chief Executive Officer
XOMA · XOMA Royalty Corp
Effective
2024-01-07
Filed
January 11, 2024, 6:59 PM ET
On January 7, 2024, the board of directors (the “Board”) of XOMA Corporation, a Delaware corporation (the “Company”), appointed Owen Hughes, previously Interim Chief Executive Officer, to serve as the Company’s Chief Executive Officer and to continue serving as principal executive officer and a director, effective immediately.
Departed

Samar Kamdar

Chief Financial Officer
BTMD · biote Corp.
Effective
2024-01-08
Successor
Robert Peterson
Filed
January 11, 2024, 6:59 PM ET
Samar Kamdar, the Company’s current Chief Financial Officer, will transition out of his role, effective immediately.
Appointed

Robert Peterson

Chief Financial Officer
BTMD · biote Corp.
Effective
2024-01-08
Filed
January 11, 2024, 6:59 PM ET
On January 8, 2024, biote Corp. (the “Company”) appointed Robert Peterson as Chief Financial Officer (principal accounting and principal financial officer) of the Company, effective immediately.
Departed

George O'Leary

Chief Financial Officer
HLYK · HealthLynked Corp
Effective
2024-04-04
Filed
January 11, 2024, 6:59 PM ET
On January 5, 2024, George O'Leary tendered his resignation as Chief Financial Officer of HealthLynked Corp., a Nevada corporation (the “ Company ”) effective April 4, 2024.
Departed

David Roman

President and Chief Executive Officer
Acutus Medical, Inc.
Effective
2024-01-07
Successor
Takeo Mukai
Filed
January 11, 2024, 6:59 PM ET
David Roman was expected to depart from his position as president and chief executive officer of the Company, as part of the Company’s strategic realignment of resources and corporate restructuring, which departure became effective January 7, 2024.
Appointed

Takeo Mukai

Chief Executive Officer
Acutus Medical, Inc.
Effective
2024-01-08
Filed
January 11, 2024, 6:59 PM ET
the Company’s board of directors approved the appointment of Takeo Mukai, the Company’s chief financial officer, as the Company’s chief executive officer, which appointment became effective January 8, 2024.
Appointed

Cheskel Meisels

Chairman of the Board and Chief Executive Officer
Fuss Brands Corp.
Effective
2024-01-10
Filed
January 11, 2024, 6:59 PM ET
Also on January 10, 2024, the shareholders of the Company elected Cheskel Meisels to act as the new Chairman of the Board of Directors of the Company.
Departed

Issamar Ginzberg

Chief Executive Officer and Director
Fuss Brands Corp.
Effective
2024-01-10
Successor
Cheskel Meisels
Filed
January 11, 2024, 6:59 PM ET
On January 10, 2024, Issamar Ginzberg tendered his resignation from the Board of Directors of Fuss Brands Corp.
Departed

Kevin L. Brackman

Chief Financial Officer
ADNH · ADVENT TECHNOLOGIES HOLDINGS, INC.
Effective
2024-01-05
Successor
Naiem Hussain
Filed
January 11, 2024, 6:59 PM ET
On January 05, 2024, Kevin L. Brackman, Chief Financial Officer of Advent Technologies Holdings, Inc., a Delaware corporation (the “Company” or “Advent”), resigned from all of his positions at the Company and its subsidiaries, effective immediately.
Role change

Naiem Hussain

Chief Financial Officer
ADNH · ADVENT TECHNOLOGIES HOLDINGS, INC.
Effective
2024-01-10
Filed
January 11, 2024, 6:59 PM ET
the Board of Directors of the Company (the “Board”) on January 10, 2024, appointed Naiem Hussain, 56, the Company’s current Chief Investment Officer, to serve as Chief Financial Officer of the Company, pending the completion of the Company’s hiring protocols.
Appointed

Jerome E. Schwind

President and Chief Executive Officer of Isabella Bank Corporation and Chief Executive Officer of Isabella Bank
ISBA · ISABELLA BANK CORP
Effective
2024-01-05
Filed
January 10, 2024, 6:59 PM ET
Subsequently, the election of Jerome E. Schwind to President and Chief Executive Officer of the Corporation and Chief Executive Officer of Isabella Bank was effective January 5, 2024.
Departed

Jae A. Evans

President and Chief Executive Officer of Isabella Bank Corporation and Chief Executive Officer of Isabella Bank
ISBA · ISABELLA BANK CORP
Effective
2024-01-04
Successor
Jerome E. Schwind
Filed
January 10, 2024, 6:59 PM ET
On January 4, 2024, Jae A. Evans retired as President and Chief Executive Officer of Isabella Bank Corporation (the “Corporation”) and Chief Executive Officer of Isabella Bank.
Appointed (interim)

Samuel Berry

Interim Chairman, Chief Executive Officer, President and Secretary
CuraScientific Corp.
Effective
2023-12-29
Filed
January 10, 2024, 6:59 PM ET
On December 29, 2023, the Board of Directors of the Company appointed Samuel Berry to serve as the Interim Chairman of the Board of the Company, Chief Executive Officer, President and Secretary.
Departed

William Reed

Chairman, CEO, Secretary and Treasurer
CuraScientific Corp.
Effective
2023-12-29
Successor
Samuel Berry
Filed
January 10, 2024, 6:59 PM ET
On December 29, 2023 William Reed resigned as Chairman, CEO, Secretary and Treasurer from Curascientific Corporation, (the “Company”).
Role change

Rob Enslin

Chief Executive Officer
PATH · UiPath, Inc.
Effective
2024-02-01
Filed
January 10, 2024, 6:59 PM ET
when he becomes UiPath’s Chief Executive Officer
Departed

Ron Shelton

Senior Vice President, Chief Financial Officer and Treasurer
NVTS · Navitas Semiconductor Corp
Effective
2024-03-15
Successor
Janet Chou
Filed
January 10, 2024, 6:59 PM ET
On January 9, 2024, Ron Shelton, Senior Vice President, Chief Financial Officer and Treasurer of Navitas Semiconductor Corporation (“Navitas” or the “Company”), announced his intention to pursue other opportunities effective March 15, 2024.
Appointed

Janet Chou

Executive Vice President, Chief Financial Officer and Treasurer
NVTS · Navitas Semiconductor Corp
Filed
January 10, 2024, 6:59 PM ET
On January 10, 2024, the Company announced the appointment of Janet Chou as Executive Vice President, Chief Financial Officer and Treasurer, effective upon the filing of the Company’s annual report on Form 10‐K for the year ended December 31, 2023, which is expected on or before February 29, 2024.
Appointed

Brett R. Larsen

President and Chief Executive Officer
KTCC · KEY TRONIC CORP
Effective
2024-06-30
Filed
January 9, 2024, 6:59 PM ET
the Board appointed Brett R. Larsen, the Company’s Executive Vice President of Administration, Chief Financial Officer and Treasurer, to succeed Mr. Gates as the Company’s President and Chief Executive Officer effective upon Mr. Gates’ retirement on June 30, 2024.
Departed

Craig D. Gates

President and Chief Executive Officer
KTCC · KEY TRONIC CORP
Effective
2024-06-30
Successor
Brett R. Larsen
Filed
January 9, 2024, 6:59 PM ET
Craig D. Gates, the President and Chief Executive Officer and member of the Board of Directors (the “Board”) of Key Tronic Corporation (the “Company”), notified the Board of his decision to retire as President and Chief Executive Officer effective June 30, 2024.
Appointed

Anthony G. Voorhees

Executive Vice President of Administration, Chief Financial Officer and Treasurer
KTCC · KEY TRONIC CORP
Effective
2024-06-30
Filed
January 9, 2024, 6:59 PM ET
the Board appointed Anthony G. Voorhees, the Company’s Vice President of Finance and Controller, to succeed Mr. Larsen as the Company’s Executive Vice President of Administration, Chief Financial Officer and Treasurer effective on June 30, 2024.
Appointed

Saori Casey

Chief Financial Officer
SONO · Sonos Inc
Effective
2024-01-22
Filed
January 9, 2024, 6:59 PM ET
On January 3, 2024, Sonos, Inc. (the “Company”) appointed Saori Casey as Chief Financial Officer (“CFO”) and principal financial officer, effective as of January 22, 2024 (the “Effective Date”).
Appointed

Julie Andrews

Chief Financial Officer
OFIX · Orthofix Medical Inc.
Effective
2024-01-15
Filed
January 9, 2024, 6:59 PM ET
the Board appointed Julie Andrews as the Company’s Chief Financial Officer, effective as of January 15, 2024
Appointed

Massimo Calafiore

President and Chief Executive Officer
OFIX · Orthofix Medical Inc.
Effective
2024-01-08
Filed
January 9, 2024, 6:59 PM ET
the Company’s Board of Directors (the “Board”) appointed Massimo Calafiore as the Company’s President and Chief Executive Officer, and Mr. Calafiore began service on such date.

Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.